Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...
from NDTV News - Latest https://ift.tt/35BsWI9
Tuesday, September 15, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment